Intended for healthcare professionals

Rapid response to:

Letters Covid 19: roll out of antibody testing

Rapid roll out of SARS-CoV-2 antibody testing—a concern

BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2420 (Published 24 June 2020) Cite this as: BMJ 2020;369:m2420

Read our latest coverage of the coronavirus pandemic

Rapid Response:

Re: Rapid roll out of SARS-CoV-2 antibody testing—a concern. An ignorant person‘s comments

Dear Editor

I know nothing about the SARS-COV-2 antibodies. Nor about the tests. Nor about the duration of persistence of the antibodies in a quantity that MIGHT protect the person from further infection (which might be sub-clinical, or clinical, or might simply and unfortunately, result in some obscure immunological reaction - with unknown , unforeseen damages to the body).

The foregoing also leads me on to the question:

Since the antibody tests are completely useless in telling one whether one is immune, partially immune or non-immune, how does a person who is injected with one of the vaccines (being currently developed in our own OXFORD) know whether he is immune, partially or completely, to infection with the wild virus? And is there a possibility that he will, when he inhales the wild virus, he will not suffer the obscure immunological reactions mentioned in the preceding paragraph?

There are other questions. But if a scientist, medical or non-medical, not employed or contracted as a public relations officer by our world class universities, can answer these questions, I will be grateful.

Competing interests: No competing interests

25 June 2020
JK Anand
Retired doctor
Free spirit
Peterborough, England